S Rafi

653 total citations
9 papers, 565 citations indexed

About

S Rafi is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, S Rafi has authored 9 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in S Rafi's work include Inflammatory mediators and NSAID effects (5 papers), Nitric Oxide and Endothelin Effects (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). S Rafi is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Nitric Oxide and Endothelin Effects (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). S Rafi collaborates with scholars based in United Kingdom, United States and India. S Rafi's co-authors include John M. Wrigglesworth, Ingvar Bjarnason, Siva G. Somasundaram, Andrew J. Macpherson, Mohan V. Jacob, G Sigthorsson, David L. Scott, Ashley B. Price, Jeremy Hayllar and Robert J. Simpson and has published in prestigious journals such as Gastroenterology, Gut and Alimentary Pharmacology & Therapeutics.

In The Last Decade

S Rafi

9 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Rafi United Kingdom 7 269 180 134 100 60 9 565
Yusaku Komoike Japan 15 301 1.1× 225 1.3× 93 0.7× 58 0.6× 70 1.2× 21 579
W. McKnight Canada 12 404 1.5× 248 1.4× 108 0.8× 90 0.9× 231 3.9× 14 791
B.D. Rush United States 12 97 0.4× 100 0.6× 145 1.1× 115 1.1× 71 1.2× 23 698
Jerry Muhammad United Kingdom 4 522 1.9× 98 0.5× 184 1.4× 75 0.8× 148 2.5× 5 872
K F Hooke United States 8 213 0.8× 70 0.4× 100 0.7× 128 1.3× 26 0.4× 9 437
Anne Wu United States 13 131 0.5× 79 0.4× 206 1.5× 43 0.4× 79 1.3× 19 651
P D Dawkins United States 12 124 0.5× 39 0.2× 140 1.0× 75 0.8× 39 0.7× 19 452
Chiyuki Yamato Japan 14 58 0.2× 153 0.8× 157 1.2× 106 1.1× 57 0.9× 34 522
Ayumu Yoshikawa Japan 10 154 0.6× 68 0.4× 254 1.9× 48 0.5× 61 1.0× 20 562
Hideaki Nagaya Japan 15 75 0.3× 319 1.8× 220 1.6× 73 0.7× 85 1.4× 29 817

Countries citing papers authored by S Rafi

Since Specialization
Citations

This map shows the geographic impact of S Rafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Rafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Rafi more than expected).

Fields of papers citing papers by S Rafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Rafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Rafi. The network helps show where S Rafi may publish in the future.

Co-authorship network of co-authors of S Rafi

This figure shows the co-authorship network connecting the top 25 collaborators of S Rafi. A scholar is included among the top collaborators of S Rafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Rafi. S Rafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Somasundaram, Siva G., et al.. (2002). 2, 4-Diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum. BMC Gastroenterology. 2(1). 8–8. 12 indexed citations
3.
Jacob, Mohan V., Ingvar Bjarnason, S Rafi, John M. Wrigglesworth, & Robert J. Simpson. (2001). A study of the effects of indometacin on liver mitochondria from rats, mice and humans. Alimentary Pharmacology & Therapeutics. 15(11). 1837–1842. 28 indexed citations
4.
Shah, Bukhtiar H., A. M. Siddiqui, Kamran Qureshi, et al.. (1999). Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathways. Experimental & Molecular Medicine. 31(1). 42–46. 38 indexed citations
5.
Mahmud, Taifo, Siva G. Somasundaram, G Sigthorsson, et al.. (1998). Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut. 43(6). 775–782. 30 indexed citations
6.
Somasundaram, Siva G., et al.. (1998). Electron paramagnetic resonance spectroscopic studies of intestinal homogenates from NSAIDs treated rats. Gastroenterology. 114. A1087–A1087. 1 indexed citations
7.
Somasundaram, Siva G., S Rafi, Jeremy Hayllar, et al.. (1997). Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine. Gut. 41(3). 344–353. 279 indexed citations
8.
Somasundaram, Siva G., S Rafi, Mohan V. Jacob, et al.. (1997). Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.. Gut. 40(5). 608–613. 25 indexed citations
9.
Somasundaram, Siva G., et al.. (1995). Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis. Scandinavian Journal of Gastroenterology. 30(4). 289–299. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026